View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Gemtuzumab Ozogamicin / Daunorubicin 35 / Cytarabine 1000, Acute Myeloid Leukemia, Induction, Cycle 2
Protocol-ID: 1 V1.1 (Mini), GEMOZO/DAUN35/CYTA1000, AML, Ind., C2Indication(s)
- Acute Myeloid Leukemia (CD33+); ICD-10 C92.0-, C92.5-, C93.0-, C92.8-, C92.6-, C92.7-, C92.9-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 02.04.2021